Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_provenance.
- NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_assertion description "[GIP response to SFA ingestion is prolonged in nondiabetic patients with NASH and is correlated with liver disease, an unfavorable dynamic adipokine profile, and beta cell dysfunction, which provides a rationale for GIP antagonism in these subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_provenance.
- NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_assertion evidence source_evidence_literature NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_provenance.
- NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_assertion SIO_000772 19141695 NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_provenance.
- NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_assertion wasDerivedFrom befree-2016 NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_provenance.
- NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_assertion wasGeneratedBy ECO_0000203 NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_provenance.
- befree-2016 importedOn "2016-02-19" NP713873.RAgTmxWWrxqNGXR5crXjb2fmF1VC-Yj4RDJ22Nxxe5cxA130_provenance.